▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Teva Pharmaceutical Industries (NYSE: TEVA)

$16.99

(0.3%)

$0.05

Price as of May 19, 2025, 3:58 p.m. ET

Teva Pharmaceutical Industries Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
TEVA	+4.48%	+41.83%	+7.24%	+5,852%
S&P	+12.45%	+100.69%	+14.95%	+2,418%

Teva Pharmaceutical Industries Company Info

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

News & Analysis

The Fool has written over 900 articles on Teva Pharmaceutical Industries.

Featured Article

Why Teva Pharmaceuticals Stock Blasted 6% Higher Today

Eric Volkman | May 12, 2025

Featured Article

Why Teva Pharmaceutical Stock Is Soaring Today

Johnny Rice | May 7, 2025

These Are My 3 Worst-Performing Stocks So Far in 2025 -- and the One I'm Buying More of Now

Matt Frankel | Mar 28, 2025

Why Teva Pharmaceutical Stock Is Sinking Today

Johnny Rice | Jan 29, 2025

My Top 10 Portfolio Holdings for 2025

Sean Williams | Dec 20, 2024

This combination of growth and value stocks has the potential to outperform the broader market in 2025 (and beyond).

What Is a Patent Cliff?

Jeremy Bowman | Nov 20, 2024

3 Bargain Stocks to Buy on the Dip

Keith Speights, David Jagielski, and Prosper Junior Bakiny | Jun 17, 2023

These stocks should be poised to rebound.

Teva Pharmaceuticals Just Made a Big Announcement, but Is It a Buy?

Alex Carchidi | Jun 5, 2023

It's unclear whether the pivot will be enough to halt its recent decline.

Valuation

Podcast Episodes

In an Ironic Twist, Generics Take Aim at Teva Pharmaceutical

Competitors make headway against Teva Pharmaceutical's top seller, and Biogen's hemophilia drugs become Bioverativ. Here's what you should know.

Todd Campbell and Kristine Harjes | Feb 7, 2017

Earnings Transcripts

Teva Pharmaceutical Industries (TEVA) Q4 2024 Earnings Call Transcript

TEVA earnings call for the period ending December 31, 2024.

Motley Fool Transcribing | Jan 29, 2025

Teva Pharmaceutical Industries (TEVA) Q3 2024 Earnings Call Transcript

TEVA earnings call for the period ending September 30, 2024.

Motley Fool Transcribing | Nov 6, 2024

Teva Pharmaceutical Industries (TEVA) Q2 2024 Earnings Call Transcript

TEVA earnings call for the period ending June 30, 2024.

Motley Fool Transcribing | Jul 31, 2024

Teva Pharmaceutical Industries (TEVA) Q1 2024 Earnings Call Transcript

TEVA earnings call for the period ending March 31, 2024.

Motley Fool Transcribing | May 8, 2024

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services